Bain said its decision to buy Mitsubishi Tanabe is due to the “strong growth potential” of Japan’s healthcare industry.

The Japanese chemical company has agreed to sell its pharmaceutical business to Bain Capital for more than $3 billion, in a ...

Japan's Mitsubishi Chemical said on Friday it will sell pharmaceutical unit Tanabe Mitsubishi Pharma to U.S. private equity ...

Bain Capital is nearing a deal to buy Mitsubishi Chemical Group Corp.’s pharmaceutical unit, people familiar with the matter ...

Mitsubishi Corp on Monday said it is reviewing how to proceed with its offshore wind projects in Japan given a "significantly ...

Japan's Mitsubishi Corp posted on Thursday a 19% increase in nine-month net profit to December to 827.4 billion yen ($5.43 ...

One of the key appeals of the new Triton is its warranty. In Australia, it comes standard with a five-year, 100,000 km ...

Mitsubishi Corp has recorded an impairment charge of Y52.2bn ($342.4m) on its offshore wind projects in Japan.

Mitsubishi Motors is facing a tough financial year, with the company slashing its net profit forecast by a staggering 76%.

The investment firm is acquiring Mitsubishi Tanabe Pharma in a deal valued at $3.3 billion. Elsewhere, Bausch + Lomb hasn’t ...

As Honda and Nissan push forward with merger plans, Mitsubishi Motors may bow out, citing doubts about its influence in the ...

Tanabe Pharma focuses on therapeutic areas such as immunology and inflammation, vaccines, diabetes, and central nervous ...